These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2182563)

  • 1. Graves' ophthalmopathy: what is the evidence for extraocular muscle specific autoantibodies.
    van der Gaag R; Vernimmen R; Fiebelkorn N; van Dierendonck MC; Kijlstra A
    Int Ophthalmol; 1990 Jan; 14(1):25-30. PubMed ID: 2182563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of antibodies in Graves' ophthalmopathy].
    Molnár I; Balázs C
    Orv Hetil; 1991 Sep; 132(38):2097-100. PubMed ID: 1923482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of Graves' ophthalmopathy.
    Kendall-Taylor P
    Clin Endocrinol Metab; 1985 May; 14(2):331-49. PubMed ID: 2415275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
    Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
    Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Muscle antigens recognized with autoantibodies in patients with Graves' ophthalmopathy].
    Adler G
    Endokrynol Pol; 1992; 43(1 Suppl):1-61. PubMed ID: 1345558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence.
    Mengistu M; Laryea E; Miller A; Wall JR
    Clin Exp Immunol; 1986 Jul; 65(1):19-27. PubMed ID: 3539423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy.
    Weightman DR; Perros P; Sherif IH; Kendall-Taylor P
    Autoimmunity; 1993; 16(4):251-7. PubMed ID: 7517705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
    Kuroki T; Ruf J; Whelan L; Miller A; Wall JR
    Clin Exp Immunol; 1985 Nov; 62(2):361-70. PubMed ID: 3841305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
    Molnár I; Balázs C
    Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' ophthalmopathy.
    Wall JR; Henderson J; Strakosch CR; Joyner DM
    Can Med Assoc J; 1981 Apr; 124(7):855-62, 866. PubMed ID: 7011529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy.
    Weetman AP; Fells P; Shine B
    Br J Ophthalmol; 1989 May; 73(5):323-7. PubMed ID: 2786428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical staining of normal and Graves' extraocular muscle.
    Tallstedt L; Norberg R
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity.
    Kendall-Taylor P; Atkinson S; Holcombe M
    Br Med J (Clin Res Ed); 1984 Apr; 288(6425):1183-6. PubMed ID: 6424781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
    Salvi M; Bingoye F; Chung F; Wall JR
    J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
    Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
    J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.
    Wu YJ; Clarke EM; Shepherd P
    Thyroid; 1998 Feb; 8(2):167-74. PubMed ID: 9510126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of autoantibodies against human eye muscle plasma membranes in Graves' ophthalmopathy.
    Faryna M; Nauman J; Gardas A
    Br Med J (Clin Res Ed); 1985 Jan; 290(6463):191-2. PubMed ID: 3917747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.